title: Screening for prostate cancer.
abstract: Carcinoma of the prostate gland is the second most common cancer among men with an age-adjusted incidence of 635 cases per 100,000 men aged 65 and older. While there are several proven methods for detecting prostate cancer, debate continues as to the best way to detect it early as well as who should receive particular screening. There are differing opinions as to proven benefit even when cancer is detected. Fortunately, newer methods continue to be developed that will hopefully reduce false positive detection rates while insuring an adequate level of screening protection.
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, MD 21215, USA.
authors.forename: S R
authors.initials: SR
authors.lastname: Gambert
mesh_terms: D000368:Aged; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods; D010808:Physical Examination; D010818:Practice Patterns, Physicians'; D011467:Prostate / Q000000981:diagnostic imaging; D017430:Prostate-Specific Antigen / Q000032:analysis; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000453:epidemiology*; D014463:Ultrasonography
chemical_list: D017430:Prostate-Specific Antigen